Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q3 2023 Earnings Call Transcript November 2, 2023 Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.15, expectations were $-1.61. Operator: Good day and thank you for standing by. Welcome to the Alnylam Pharmaceuticals Q3 2023 Earnings Conference Call. At this time, participants are in a listen-only mode. After the […]
Related Keywords
United States ,Netherlands ,Canada ,United Kingdom ,Jeff Poulton ,Christine Lindenboom ,Novartis ,Disease Conference ,Fitness Apps ,Performing Disney Animated Movies ,Alnylam Pharmaceuticals ,Yvonne Greenstreet ,Systolic Blood Pressure ,Pushkal Garg ,Amvuttra ,Tolga Tanguler ,Sttr ,
comparemela.com © 2020. All Rights Reserved.